News & Articles

Dr. Priya Chockalingam discusses the complexities of cell and gene therapies and how single-cell multimodal analysis can efficiently characterize gene-edited products

The vaccine quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor

Learn how Thermo Fisher Scientific’s Cytomat™ 2 Selector Automated Shaking Incubator can enable biologics to reach the market faster

In the fast-paced world of science, knowledge drives progress, and The Bio-Rad Academy leads the charge

New line of GTxResolve Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics

Explore the applications of cell counting through their context of use

Discover the latest technology to supercharge your gene therapy vector analysis workflow

The new scaffolding material promises to be damage-resistant, not generate debris, and enable the safe and efficient culturing of cells

Explore the latest technologies and techniques that will help you advance biopharma pipelines

Antibodies validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples

Expand horizons in life science research and discover the power of real-time cell monitoring

Validated detection of viral replication genes using Droplet Digital™ PCR during cell and gene therapy production

Find out which lab products scientists are using to advance the field and what their experiences have been

New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technologies developed at the University of Sheffield

Discover how the Wellcome Sanger Institute is helping to develop a physical atlas of all human organs

Explore how the latest advancements and recent regulatory approvals are making truly personalized medicine a reality

As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality

Automated workflows from single-cell dispensing to 3D spheroid analysis

Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived organ-on-a-chip solution for more accurate in vitro ADME predictions

Casgevy™ and Lyfgenia™ approvals pave the way for personalized gene editing therapies in treating sickle cell disease

Innovation provides United States with first workflow update in 25 years

Artificial cells, made with the use of synthetic materials, have been produced in international research led by the University of Strathclyde

Learn about the latest developments in cancer research with fellow scientists, manufacturers, and regulatory experts

From monoclonality to droplet-based technology, find out the key to cell line development success

The partnership aims to enable single cell workflow automation